These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3382303)

  • 1. Clinical symptoms and length of survival in patients with terminal cancer.
    Reuben DB; Mor V; Hiris J
    Arch Intern Med; 1988 Jul; 148(7):1586-91. PubMed ID: 3382303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive model for survival in patients with advanced cancer.
    Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
    J Clin Oncol; 2008 Dec; 26(36):5863-9. PubMed ID: 19018082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic.
    Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):280-7. PubMed ID: 18676092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The symptoms of advanced cancer.
    Donnelly S; Walsh D
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):67-72. PubMed ID: 7537907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and survival prediction in terminal cancer patients: a multicenter study.
    Vigano A; Donaldson N; Higginson IJ; Bruera E; Mahmud S; Suarez-Almazor M
    Cancer; 2004 Sep; 101(5):1090-8. PubMed ID: 15329920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Standards, options and recommendations: nutritional support in palliative or terminal care of adult patients with progressive cancer].
    Bachmann P; Marti-Massoud C; Blanc-Vincent MP; Desport JC; Colomb V; Dieu L; Kere D; Melchior JC; Nitenberg G; Raynard B; Roux-Bournay P; Schneider S; Senesse P
    Bull Cancer; 2001 Oct; 88(10):985-1006. PubMed ID: 11713035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival chances of Hungarian cancer patients in the National Cancer Registry].
    Tusnády G; Gaudi I; Rejto L; Kásler M; Szentirmay Z
    Magy Onkol; 2008 Dec; 52(4):339-49. PubMed ID: 19068461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial neural networks estimating survival probability after treatment of choroidal melanoma.
    Damato B; Eleuteri A; Fisher AC; Coupland SE; Taktak AF
    Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer.
    Glare PA; Eychmueller S; McMahon P
    J Clin Oncol; 2004 Dec; 22(23):4823-8. PubMed ID: 15570085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical estimation of survival and impact of other prognostic factors on terminally ill cancer patients in Oman.
    Faris M
    Support Care Cancer; 2003 Jan; 11(1):30-4. PubMed ID: 12527951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting survival in patients with advanced disease.
    Glare P; Sinclair C; Downing M; Stone P; Maltoni M; Vigano A
    Eur J Cancer; 2008 May; 44(8):1146-56. PubMed ID: 18394880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of carcinoma and chronology (study of time) of cancer].
    Kusama S
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):559-69. PubMed ID: 6764109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer.
    Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1169-76. PubMed ID: 18938045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a prognostic scale for use in patients with advanced cancer.
    Stone P; Kelly L; Head R; White S
    Palliat Med; 2008 Sep; 22(6):711-7. PubMed ID: 18715969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of symptoms of hospitalised advanced cancer patients.
    Teunissen SC; de Graeff A; de Haes HC; Voest EE
    Eur J Cancer; 2006 Oct; 42(15):2510-6. PubMed ID: 16962316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
    Bottomley A; Coens C; Efficace F; Gaafar R; Manegold C; Burgers S; Vincent M; Legrand C; van Meerbeeck JP;
    J Clin Oncol; 2007 Dec; 25(36):5770-6. PubMed ID: 18089874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience.
    Hoda D; Jatoi A; Burnes J; Loprinzi C; Kelly D
    Cancer; 2005 Feb; 103(4):863-8. PubMed ID: 15641035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.